WELL Health: A Growth Stock to Consider for Your Portfolio

If you are looking to invest in undervalued growth stocks, WELL Health is a top bet right now.

| More on:
healthcare pharma

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more

In the last decade, growth stocks have been on an absolute tear and have crushed the broader markets by a huge margin. Growth stocks remain an enticing bet for long-term investors, as these companies are able to grow revenue and profit margins at a rapid pace, thereby generating exponential returns over time.

One such growth stock on the TSX is WELL Health Technologies (TSX:WELL), a company that I have extensively covered in the last week. Right now, this digital health stock is trading at an attractive valuation and has significant upside potential given recent developments.

WELL Health is at the top of my radar again, as the company disclosed it is the first Canadian EMR (electronic medical record) and telehealth platform to offer Apple Health Records in Canada.

This means that anyone with an iPhone already has the app (it comes factory installed on every phone), which can retrieve health records from participating clinics. WELL Health set out to modernize healthcare, and this is more proof that they are making this happen. This collaboration with Apple is likely just the beginning of what is coming.

The company’s chairman and CEO Hamed Shahbazi said, “We are delighted to be the first telehealth and Canadian EMR platform in Canada to offer health records and enable patients to download and view their health information on iPhone. Providing patients with an easy and convenient method to get access to their available health records right on their iPhone can help them more actively participate in their health, leading to better health outcomes and a higher patient understanding of their own overall health status.”

I believe WELL has what it takes to remain a top bet for 2021 and beyond.

Focus on acquisitions

WELL Health is a company that has grown via accretive acquisitions over the years. Last month, it completed the acquisition of Intrahealth, which is an enterprise-class EMR provider with a global network of healthcare customers in Australia, Canada, and New Zealand.

In March, WELL Health disclosed it made an early-stage seed investment in Twig Fertility which is a start-up fertility clinic. In order to acquire CRH Medical, WELL Health completed an equity offering totaling over $300 million, which was led by noted Hong Kong investor Li Ka-Shing and several other institutions.

In January, WELL Health acquired Open Health Software Solutions, which is an OSCAR service provider to medical clinics in Ontario. It also acquired Adracare, which is an omnichannel practice management platform that serves 6,800 allied healthcare practitioners in five countries.

Last year, WELL expanded to Quebec after it acquired ExcelleMD, a healthcare entity that provides in-person and virtual care services via its five multi-disciplinary clinics.

WELL Health is trading at an attractive valuation

Driven by its slew of acquisitions, WELL Health is forecast to increase sales by a stellar 353% to $227.6 million in 2021. Further, analysts expect sales to increase by 43% to $325 million in 2022. While it posted an adjusted loss in 2020, WELL Health is expected to report earnings of $0.01 per share this year and $0.08 in 2022.

It means, WELL stock is trading at a forward price-to-sales multiple of less than six, which is very reasonable for a high-growth company.

Bay Street believes WELL Health stock is undervalued and has a 12-month average target price of $11.56, which is 68% above its current trading price.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

David Gardner owns shares of Apple. The Motley Fool owns shares of and recommends Apple and recommends the following options: short March 2023 $130 calls on Apple and long March 2023 $120 calls on Apple. Fool contributor Aditya Raghunath has no position in any of the stocks mentioned.

More on Investing

Cogs turning against each other

Top 2 Stocks That Could Beat the Recession

Recession-resistant stocks like Dollarama (TSX:DOL) should be on your radar in 2022.

Read more »

edit Person using calculator next to charts and graphs
Dividend Stocks

The 3 Best Dividend Stocks for Monthly Passive Income

These three dividend stocks are the best options for those seeking high passive income in the next few years in…

Read more »

clock time
Dividend Stocks

Got $10,000 to Invest? 1 Cheap TSX Stock to Buy Right Now

This top TSX dividend stock is finally on sale and has made some savvy buy-and-hold investors quite rich.

Read more »

A close up image of Canadian $20 Dollar bills
Dividend Stocks

Want Monthly Passive Income? These TSX Dividend Stocks Are for You

If you want monthly passive income from TSX stocks, you have to do a little digging. I've given you a…

Read more »

Hand arranging wood block stacking as step stair with arrow up.
Bank Stocks

The Most Valuable TSX Stock Out There Is up 10% This Month!

This TSX stock is the best value stock out there, expanding even during a downturn and setting itself up from…

Read more »

ETF chart stocks
Dividend Stocks

3 International ETFs to Buy for a Diversified Portfolio

Some international markets may prove more resilient against economic downturns, and exposure to them may strengthen your portfolio during crashes…

Read more »

Payday ringed on a calendar
Dividend Stocks

TFSA Pension: 3 Canadian Dividend Stocks to Buy for Monthly Passive Income

These high-yield Canadian stocks look good to buy right now for a TFSA focused on monthly passive income.

Read more »

A worker uses a laptop inside a restaurant.
Tech Stocks

2 U.S. Stocks Canadian Investors Can Buy and Hold Forever

Blue-chip companies such as Microsoft and Coca-Cola are forever stocks that have the potential to beat the market in 2022…

Read more »